Neotrofin leteprinim (AIT-082): Began Phase II/III trial

NeoTherapeutics Inc. (NEOT), Irvine, Calif.
Product: Neotrofin leteprinim

Read the full 82 word article

How to gain access

Continue reading with a
two-week free trial.